Cardiopulmonary Exercise Market by Product Type (Cardiopulmonary Exercise Testing Systems, Echocardiogram), Application (Oxygen Uptake), End-Use (Hospitals & clinics), and Region (Asia Pacific, Europe, North America, Middle East, and Africa, Latin America), and forecast period-2022 – 2030

Report ID - MRC_797 | Pages - 187 | Category - Healthcare and Pharma

The cardiopulmonary exercise market is projected to be worth USD 5.1 Billion by 2030, registering a CAGR of 4.7% during the forecast period (2022-2030), the market was valued at USD 3.4 Billion in 2021. Cardiopulmonary exercise testing provides accurate assessments of heart and lung performance during surgical setting exercises. The vital health-diagnostic data such as heart rate, EKG, oxygen uptake, and carbon dioxide output are collected in testing for pre-operative risk assessment and diagnosis of cardiopulmonary diseases. 

The rise in the number of global cardiovascular diseases and increased demand for stress testing procedures contribute to the growth of the cardiopulmonary exercise market. For instance, the recent data published by the European Heart network in 2021 surveyed that more than 60 million people are diagnosed with cardiovascular diseases in the European Union. In the case of the cardiopulmonary exercise market, cardiopulmonary exercise testing (CPET) systems contribute the largest market share over the forecast period. According to the study published in May 2022 named “Cardiopulmonary Exercise Testing and Efficacy of Percutaneous Coronary Intervention: A Substudy of the Orbita Trial”, there is a correlation between specific cardiopulmonary exercise testing (CPET) parameters with the detection of myocardial ischemia symptoms. In 2021, North America is anticipated to contribute the largest market share due to increased investments in medical infrastructure, higher purchasing power, and availability of advanced medical treatment devices. Thus, due to the above-mentioned factors, the cardiopulmonary exercise market is estimated to grow during the forecast period.

Cardiopulmonary Exercise Market Dynamics:

A cardiopulmonary exercise testing (CPET), also known as the VO2 (oxygen consumption) test, is a clinical assessment that provides information about heart and lung rates. The CPET helps to better understand the root cause of cardiopulmonary diseases, determine exercise capability, and pre-assessment of risks before major surgery.

Driver:

The globally rising and recurring rates of cardiovascular and pulmonary diseases such as heart valve imbalance, atrial fibrillation, and arrhythmia are anticipated to drive the growth of the cardiopulmonary exercise market. Moreover, the increased sedentary lifestyle incidences and the rise in the number of the aged population are major factors driving the growth of the market.

Restraint:

The higher price of medical devices and instruments used in cardiopulmonary exercises are expected to obstruct the growth of the cardiopulmonary exercise market. Additionally, the complex regulations and protocols laid by the regulatory authorities and the increasing number of challenges in the development stage are anticipated to hamper the market growth.

Opportunity:

The growing number of research and development studies in the area of cardiopulmonary stress tests for detecting cardiovascular and pulmonary conditions are expected to generate profitable opportunities for market growth. Furthermore, increased awareness of cardiovascular disease assessment and relevant body monitoring techniques are expected to offer lucrative opportunities for the growth of the cardiopulmonary exercise market.

COVID-19 Analysis of Cardiopulmonary Exercise Market:

The cardiopulmonary exercise market has been significantly impacted due to the COVID-19 pandemic in many different parts of the world. The factors such as poor supply chain, slow medical device manufacturing rate, limited availability of raw materials, and economic slowdown are the major impacts of COVID-19 on hampered the growth of the cardiopulmonary exercise market. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the cardiopulmonary exercise market is moderate. Post covid-19 there was a positive impact on the cardiopulmonary exercise market as consumers were more focused on health.

Cardiopulmonary Exercise Report Coverage:

Report AttributesReport Details
Study Timeline2016-2030
Market Size in 2030 (USD Billion)5.1 Billion
CAGR (2022-2030)4.7%
By Product TypeSingle-Photon Emission Computed Tomography (SPECT), Cardiopulmonary Exercise Testing (CPET) Systems, Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors, Others
By ApplicationOxygen Uptake, Carbon Dioxide, Minute Ventilation, and Anaerobic Threshold
By End-Use Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, and others
By GeographyNorth America– (U.S., Canada, Mexico

Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)

Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)

Latin America- (Brazil, Argentina, Chile, Rest of Latin America)

Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)

Key PlayersCardinal Health, COSMED SRL, GE Healthcare, Hill-Rom Holdings Inc., Koninklijke Philips NV, MGC Diagnostics Corporation, Nihon Kohden Corporation, Schiller AG, Masimo Corporation, Vyaire Medical Inc.

Cardiopulmonary Exercise Market Segment Analysis:

By Product Type

The product type segment is divided into single-photon emission computed tomography (SPECT), cardiopulmonary exercise testing (CPET) systems, echocardiogram, pulse oximeters, stress blood pressure monitors, and others. The cardiopulmonary exercise testing (CPET) systems segment is estimated to contribute the largest share of the market due to the cost-effectiveness and precision of these testing. The CPET system evaluates the exercise responses based on circulatory, pulmonary, cognitive, and skeletal muscle systems for effective outcomes of each organ’s functions.  Additionally, the features such as versatility, higher preference by physicians, and reduced operating time are anticipated to support the segment growth in the forecast period.

cardiopulmonary exercise market by product

By Application

The application segment is divided into oxygen uptake, carbon dioxide, minute ventilation, and anaerobic threshold. The oxygen uptake segment has the largest share contribution to the growth of the cardiopulmonary exercise market. Owing to the determination of functional aerobic capacity and precise laboratory measurement. In the case of cardiopulmonary exercise, maximal oxygen uptake is the term used to describe the amount of oxygen used by the body during physical exercise Furthermore, the evaluation of oxygen uptake levels helps in determining the upper limit of endurance performance for assessing the efficacy of treatment procedures. Additionally, carbon dioxide, minute ventilation, and anaerobic threshold are also expected to support the growth of the cardiopulmonary exercise market.

By End-Use

The end-user segment is categorized into hospitals & clinics, diagnostic centers, ambulatory surgical centers, and others. The hospital & clinics segment held the leading share in the cardiopulmonary exercise market. The growing number of global patients diagnosed with ailments such as heart failure, arrhythmia, and related heart valve complications is the key factor fueling the segment’s growth. The factors such as favorable reimbursement policies combined with the rise in advanced medical devices are expected to augment the growth of the hospitals & clinics segment during the projected period. Thus, the above-mentioned segments are expected to accelerate the growth of the cardiopulmonary exercise market in the forecast period.

cardiopulmonary exercise market by end use

By Region

The regional segment includes Asia Pacific, Europe, North America, Middle East, and Africa, Latin America. In 2021, North America had the largest share in the growth of the cardiopulmonary exercise market. The United States in North America is anticipated to record significant growth during the forecast period. Due to the growing numbers of cardiovascular and pulmonary disorders such as dyspnea, arrhythmia, and ischemic heart disease combined with the high demand for cardiopulmonary exercise testing. Additionally, the higher availability of advanced medical treatment devices and increased investments from the government boost the growth of the cardiopulmonary exercise market in the North American region.

The Asia Pacific is also expected to dominate the growth of the cardiopulmonary exercise market during the forecast period. Further, China led the growth of the market due to the developing healthcare infrastructure, rise in the numbers of geriatric population, and increased prevalence of cardiopulmonary exercise diseases that fuel the market growth in the Asia Pacific region.

Cardiopulmonary Exercise Market Competitive Landscape:

The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Application launches have accelerated the growth of the Sample Preparation market. Key players in the market include-

  • Cardinal Health
  • COSMED SRL
  • GE Healthcare
  • Hill-Rom Holdings Inc.
  • Koninklijke Philips NV
  • MGC Diagnostics Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Masimo Corporation
  • Vyaire Medical Inc.

Recent Development

  • In February 2022, a company based in South Korea named InBody launched a device called BP 170 automatic blood pressure monitor, which helps individuals in self-recording and tracking the major health metrics at home.
  • In 2022, AliveCor introduced the most convenient and compact personal ECG device named KardiaMobile Card which provides a medical-grade, single-lead ECG within 30 seconds.
  • In 2022, Glo-Med Networks partnered with Inspira to distribute the device named Hyla non-invasive blood sensor which provides real-time blood monitoring without using actual patients’ blood samples.

Table of Content

  1. Introduction
    • Market Introduction
    • Market Research Methodology
      • Research Process
      • Primary Research
      • Secondary Research
      • Data Collection Technique
      • Data Sources
    • Market Estimation Methodology
      • Limitations of the Study
    • Product Picture of Cardiopulmonary Exercise
    • Global Cardiopulmonary Exercise Market: Classification
    • Geographic Scope
    • Years Considered for the Study
    • Research Methodology in brief
    • Parent Market Overview
    • Overall Cardiopulmonary Exercise Market Regional Demand
    • Research Programs/Design
    • Market Breakdown and Data Triangulation Approach
    • Data Source
    • Secondary Sources
    • Primary Sources
    • Primary Interviews
    • Average primary breakdown ratio
  2. Market Dynamics
    • Drivers
      • Drivers
    • Restraints
      • Restraints
    • Opportunity
      • Impact forces on market dynamics
      • Impact forces during the forecast years
    • Industry Value Chain
      • Upstream analysis
      • Downstream analysis
      • Distribution Channel
      • Direct Channel
      • Indirect Channel
    • Potential Customers
    • Manufacturing/Operational Cost Analysis
    • Pricing Analysis by Region
    • Key Technology Landscape
    • Regulatory Analysis
    • Porter’s Analysis
      • Supplier Power
      • Buyer Power
      • Substitution Threat
      • Threat from New Entry
      • Competitive Rivalry
    • PESTEL Analysis
    • Political Factors
    • Economic Factor
    • Social Factors
    • Technological Factor
    • Environmental Factors
    • Legal Factor
    • Covid-19 impact on Global Economy
    • Covid-19 impact on Cardiopulmonary Exercise demand
    • Post-Covid Impact on Cardiopulmonary Exercise Market Demand
    • Impact Analysis of Russia-Ukraine Conflict
  3. Global Cardiopulmonary Exercise Market Segmentation, by Revenue (USD Billion), (2022-2030)
    • By Product Type
      • Single-photon emission computed tomography (SPECT)
      • Stress Blood Pressure Monitors
      • Cardiopulmonary exercise testing (CPET) systems
      • Echocardiogram
      • Pulse Oximeters
      • Others
    • By Application
      • Oxygen Uptake
      • Carbon Dioxide
      • Minute Ventilation
      • Anaerobic Threshold
    • By End Use
      • Hospitals & clinics
      • Ambulatory surgical centers
      • Diagnostic Centers
      • Others
  1. Global Cardiopulmonary Exercise Market Overview, By Region
    • North America Cardiopulmonary Exercise Market Revenue (USD Billion), by Countries, (2022-2030)
      • US
        • By Product Type
        • By Application
        • By End Use
      • Canada
      • Mexico
    • Europe Cardiopulmonary Exercise Market Revenue (USD Billion), by Countries, (2022-2030)
      • France
      • UK
      • Spain
      • Russia
      • Italy
      • BENELUX
    • Asia Pacific Cardiopulmonary Exercise Market Revenue (USD Billion), by Countries, (2022-2030)
      • China
      • Japan
      • Australia
      • South Korea
      • India
      • ASEAN
  1. Latin America Cardiopulmonary Exercise Market Revenue (USD Billion), by Countries, (2022-2030)
    • Brazil
    • Argentina
    • Chile
  2. Middle East and Africa Cardiopulmonary Exercise Market Revenue (USD Billion), by Countries, (2022-2030)
    • GCC
    • Turkey
    • South Africa
  3. Global Cardiopulmonary Exercise Market Revenue: Competitive Analysis, 2021
    • Key strategies by players
    • Revenue (USD Billion and %), By manufacturers, 2021
    • Player Positioning by Market Players, 2021
  4. Competitive Analysis
    • Cardinal Health
      • Business Overview
      • Business Financials (USD Million)
      • Product Category, Type, and Specification
      • Main Business/Business Overview
      • Geographical Analysis
      • Recent Development
      • Swot Analysis
    • COSMED SRL
    • GE Healthcare
    • Hill-Rom Holdings Inc.
    • Koninklijke Philips NV
    • MGC Diagnostics Corporation
    • Nihon Kohden Corporation
    • Schiller AG
    • Masimo Corporation
    • Vyaire Medical Inc.
  5. Market Research Findings & Conclusion

Disclaimer

Research Methodology

The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.

Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
Back to top button